For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Nereus Pharmaceuticals, Inc.

USPTO Granted Patents = 36

% Expired Patents = 38.9

CIPO Patents = 3

EPO Patents = 6

Forward Citations = 543

Loading Chart...

Loading Chart...

44 inventors (with patents filed for the assignee):

Michael A Palladino (16 out of 24 patents)

Barbara Christine Potts (11 out of 12 patents)

Yoshio Hayashi (8 out of 10 patents)

4. Kin S Lam (7 out of 32 patents)

5. Emmanuel A Theodorakis (6 out of 17 patents)

6. Venkata Rami Reddy Macherla (6 out of 7 patents)

7. Ta-Hsiang Chao (6 out of 7 patents)

8. Jennifer Grodberg (6 out of 6 patents)

9. Benjamin Nicholson (6 out of 7 patents)

10. Rama Manam (5 out of 13 patents)

11. Katherine A McArthur (5 out of 6 patents)

12. Venkat Rami Reddy Macherla (4 out of 8 patents)

13. Saskia Theodora Cornelia Neuteboom (4 out of 5 patents)

14. Taotao Ling (4 out of 4 patents)

15. Scott Sherman Mitchell (4 out of 4 patents)

Core Competencies:

Salinosporamide A

Proteasome Inhibitors

Dehydrophenylahistins

Anti-Cancer Compounds

Heterocyclic Compounds

Interleukin Modulators

Oxazolidinones

Biosyntheses

Tricyclic Diterpenes

Spiro Beta-Lactone

Phenylahistin

Diketopiperazines

36 patents: Sort by Forward Citations

1. 8314251 - Total synthesis of salinosporamide A and analogs thereof (2012-11-20),

2. 8247552 - Analogs of dehydrophenylahistins and their therapeutic use (2012-08-21),

3. 8227503 - Proteasome inhibitors (2012-07-24),

4. 8168803 - Methods of using [3.2.0] heterocyclic compounds and analogs thereof (2012-05-01),

5. 8133915 - Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators (2012-03-13),

6. 8067616 - Total synthesis of salinosporamide A and analogs thereof (2011-11-29),

7. 8003802 - Total synthesis of Salinosporamide A and analogs thereof (2011-08-23),

8. 7956058 - Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof (2011-06-07),

9. 7935704 - Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof (2011-05-03),

10. 7919497 - Analogs of dehydrophenylahistins and their therapeutic use (2011-04-05),

11. 7910616 - Proteasome inhibitors (2011-03-22),

12. 7893299 - Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators (2011-02-22),

13. 7879892 - Anti-cancer and anti-microbial oxazolidinones (2011-02-01),

14. 7842814 - Total synthesis of salinosporamide A and analogs thereof (2010-11-30),

15. 7824698 - Lyophilized formulations of Salinosporamide A (2010-11-02),

Company Overview

Nereus Pharmaceuticals, Inc. is a biotechnology company based in San Diego, California, focused on the discovery and development of innovative therapies for cancer and other serious diseases. The company specializes in leveraging its proprietary drug discovery platform to identify and optimize small molecules that target specific biological pathways. Nereus is committed to advancing its research in oncology and related fields, aiming to address unmet medical needs through its cutting-edge scientific approach.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

36 Patents

#174 in San Diego, CA

#2,245 in California

#9,502 in US

#18,716 in the World

San Diego, CA, United States of America

Nereus Pharmaceuticals, Inc.

Forward Citations = 543

44 inventors:

Michael A Palladino (16 out of 24 patents)

Barbara Christine Potts (11 out of 12 patents)

Yoshio Hayashi (8 out of 10 patents)

4. Kin S Lam (7 out of 32 patents)

5. Emmanuel A Theodorakis (6 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nereus Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/nereus-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…